CN102617643B - 一种核黄素磷酸钠化合物 - Google Patents
一种核黄素磷酸钠化合物 Download PDFInfo
- Publication number
- CN102617643B CN102617643B CN 201210058163 CN201210058163A CN102617643B CN 102617643 B CN102617643 B CN 102617643B CN 201210058163 CN201210058163 CN 201210058163 CN 201210058163 A CN201210058163 A CN 201210058163A CN 102617643 B CN102617643 B CN 102617643B
- Authority
- CN
- China
- Prior art keywords
- riboflavin
- anhydrous
- compound according
- phosphate sodium
- degrees
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229950001574 riboflavin phosphate Drugs 0.000 title claims abstract description 59
- -1 Riboflavin sodium phosphate compound Chemical class 0.000 title abstract description 5
- 239000013078 crystal Substances 0.000 claims abstract description 42
- 150000001875 compounds Chemical class 0.000 claims abstract description 32
- 239000002245 particle Substances 0.000 claims abstract description 17
- 238000000634 powder X-ray diffraction Methods 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910017488 Cu K Inorganic materials 0.000 claims abstract description 8
- 229910017541 Cu-K Inorganic materials 0.000 claims abstract description 8
- OHSHFZJLPYLRIP-BMZHGHOISA-M Riboflavin sodium phosphate Chemical compound [Na+].OP(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O OHSHFZJLPYLRIP-BMZHGHOISA-M 0.000 claims description 46
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 32
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 17
- 235000019192 riboflavin Nutrition 0.000 claims description 17
- 239000002151 riboflavin Substances 0.000 claims description 17
- 229960002477 riboflavin Drugs 0.000 claims description 17
- 239000012046 mixed solvent Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 230000005260 alpha ray Effects 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000012065 filter cake Substances 0.000 claims description 7
- 239000006104 solid solution Substances 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 5
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims description 4
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 4
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 abstract description 53
- 238000002474 experimental method Methods 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 description 22
- 238000000034 method Methods 0.000 description 13
- 239000000843 powder Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 8
- 238000002425 crystallisation Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000013112 stability test Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 238000004088 simulation Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- FCASKLHVRFDIJB-UHFFFAOYSA-N Riboflavine Natural products Cc1cc2N=C3C(NC(=O)NC3=O)N(CC(O)C(O)C(O)CO)c2cc1C FCASKLHVRFDIJB-UHFFFAOYSA-N 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011768 flavin mononucleotide Substances 0.000 description 2
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000008558 metabolic pathway by substance Effects 0.000 description 2
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 2
- 150000003287 riboflavins Chemical class 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Abstract
Description
溶解度(g/100ml) | |
实施例1 | 0.182 |
实施例1 | 0.180 |
实施例1 | 0.183 |
实施例1 | 0.182 |
对比药物 | 0.108 |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210058163 CN102617643B (zh) | 2012-03-06 | 2012-03-06 | 一种核黄素磷酸钠化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210058163 CN102617643B (zh) | 2012-03-06 | 2012-03-06 | 一种核黄素磷酸钠化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102617643A CN102617643A (zh) | 2012-08-01 |
CN102617643B true CN102617643B (zh) | 2013-04-10 |
Family
ID=46557895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210058163 Active CN102617643B (zh) | 2012-03-06 | 2012-03-06 | 一种核黄素磷酸钠化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102617643B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104072540B (zh) * | 2014-05-22 | 2016-08-17 | 深圳朗欧医药集团有限公司 | 核黄素磷酸钠化合物及其制备方法 |
CN106674225B (zh) * | 2016-11-09 | 2019-04-02 | 珠海同源药业有限公司 | 一种核黄素磷酸钠化合物及其药物组合物 |
CN111094309A (zh) * | 2018-09-21 | 2020-05-01 | 邦泰生物工程(深圳)有限公司 | 高纯度核黄素磷酸钠的制备方法 |
CN114702524A (zh) * | 2022-04-29 | 2022-07-05 | 湖北广济药业股份有限公司 | 一种制备高纯度核黄素磷酸钠的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU166356A1 (ru) * | 1961-12-15 | 1964-11-19 | Способ получения рибофлавип-5'-фосфата натрия | |
US4987229A (en) * | 1988-03-31 | 1991-01-22 | Basf Aktiengesellschaft | Purification of salts of riboflavin 5'-phosphate, in particular of monosodium riboflavin 5'-phosphate |
US5017700A (en) * | 1988-10-19 | 1991-05-21 | Basf Aktiengesellschaft | Preparation of riboflavin-5'-phosphate (5'-FMN) and its sodium salt, and of riboflavin-4',5'-cyclophosphoric acid ester chloride as an intermediate |
US5095115A (en) * | 1989-09-14 | 1992-03-10 | Basf Aktiengesellschaft | Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone |
EP0523582A1 (de) * | 1991-07-19 | 1993-01-20 | BASF Aktiengesellschaft | Verbessertes Verfahren zur Herstellung des Mononatriumsalzes von Riboflavin 5'-phosphat |
WO2003010172A1 (en) * | 2001-07-23 | 2003-02-06 | Eisai Co., Ltd. | Process for producing highly pure riboflavin-5’-phosphate sodium |
CN102206233A (zh) * | 2011-04-06 | 2011-10-05 | 湖北广济药业股份有限公司 | 核黄素磷酸酯钠的工业化制备方法 |
CN102260291A (zh) * | 2011-04-29 | 2011-11-30 | 周晓东 | 一种核黄素磷酸钠晶体化合物、其药物组合物及制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3901321B2 (ja) * | 1997-06-05 | 2007-04-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | リボフラビン−5’−リン酸またはそのナトリウム塩の製造法 |
-
2012
- 2012-03-06 CN CN 201210058163 patent/CN102617643B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU166356A1 (ru) * | 1961-12-15 | 1964-11-19 | Способ получения рибофлавип-5'-фосфата натрия | |
US4987229A (en) * | 1988-03-31 | 1991-01-22 | Basf Aktiengesellschaft | Purification of salts of riboflavin 5'-phosphate, in particular of monosodium riboflavin 5'-phosphate |
US5017700A (en) * | 1988-10-19 | 1991-05-21 | Basf Aktiengesellschaft | Preparation of riboflavin-5'-phosphate (5'-FMN) and its sodium salt, and of riboflavin-4',5'-cyclophosphoric acid ester chloride as an intermediate |
US5095115A (en) * | 1989-09-14 | 1992-03-10 | Basf Aktiengesellschaft | Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone |
EP0523582A1 (de) * | 1991-07-19 | 1993-01-20 | BASF Aktiengesellschaft | Verbessertes Verfahren zur Herstellung des Mononatriumsalzes von Riboflavin 5'-phosphat |
WO2003010172A1 (en) * | 2001-07-23 | 2003-02-06 | Eisai Co., Ltd. | Process for producing highly pure riboflavin-5’-phosphate sodium |
CN102206233A (zh) * | 2011-04-06 | 2011-10-05 | 湖北广济药业股份有限公司 | 核黄素磷酸酯钠的工业化制备方法 |
CN102260291A (zh) * | 2011-04-29 | 2011-11-30 | 周晓东 | 一种核黄素磷酸钠晶体化合物、其药物组合物及制备方法 |
Non-Patent Citations (5)
Title |
---|
"利用核黄素粗品制备核黄素5"-磷酸钠";魏转等;《中国食品添加剂》;20111231(第06期);第49-55页 * |
"核黄素磷酸钠生产工艺的研究";孙文敬等;《食品科学》;20081231;第29卷(第8期);第188-190页 * |
JP特开平11-49790A 1999.02.23 |
孙文敬等."核黄素磷酸钠生产工艺的研究".《食品科学》.2008,第29卷(第8期),第188-190页. |
魏转等."利用核黄素粗品制备核黄素5"-磷酸钠".《中国食品添加剂》.2011,(第06期),第49-55页. |
Also Published As
Publication number | Publication date |
---|---|
CN102617643A (zh) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102617643B (zh) | 一种核黄素磷酸钠化合物 | |
CN105001289A (zh) | 一种乙酰氨基阿维菌素的精制方法 | |
CN101297809B (zh) | 头孢哌酮钠与舒巴坦钠混粉的制备方法 | |
CN103524532B (zh) | 一种头孢唑肟钠化合物晶型、制备方法及其药物制剂 | |
CN102276533B (zh) | 一种新的奥扎格雷钠化合物及其药物组合物 | |
CN102367229B (zh) | 一种二乙酰氨乙酸乙二胺化合物及其药物组合物 | |
CN103145736B (zh) | 一种含有头孢孟多酯钠化合物的药物组合物 | |
CN104958318A (zh) | 一种治疗感染性疾病的药物舒巴坦钠组合物 | |
CN105520942A (zh) | 一种氨苄西林钠舒巴坦钠的药物组合物 | |
CN102260291B (zh) | 一种核黄素磷酸钠化合物及其制备 | |
CN102657606B (zh) | 一种供静脉给药用的硫辛酸注射液 | |
CN102727451A (zh) | 一种含有头孢美唑钠的药物组合物 | |
CN103735522B (zh) | 一种炎琥宁冻干粉针及其制备方法 | |
CN102973569A (zh) | 一种头孢米诺钠无菌混合粉形式的药物组合物 | |
CN103304604B (zh) | 一种克林霉素磷酸酯化合物,其制备方法及其药物组合物 | |
CN102716075B (zh) | 一种含有头孢唑肟钠的药物组合物 | |
JP6887025B2 (ja) | 安定型ニコチンアミドリボシド組成物及びその調製方法 | |
CN102145001A (zh) | 稳定的氨曲南组合物及其制备方法 | |
CN104844624A (zh) | 一种头孢哌酮钠舒巴坦钠共晶与组合物及其制备方法 | |
CN104771374A (zh) | 一种注射用乳糖酸阿奇霉素冻干粉针剂的制备方法及其制备的冻干粉针剂 | |
CN102198105B (zh) | 萘夫西林钠注射剂及其制备方法 | |
CN103494778B (zh) | 一种埃索美拉唑钠冻干制剂及其制备方法 | |
CN114159432B (zh) | 一种替卡西林钠克拉维酸钾药物组合物及其制备方法 | |
CN102827147A (zh) | 一种奥美拉唑钠晶体化合物及含有该晶体化合物的药物组合物 | |
CN102327240B (zh) | 一种注射用头孢拉宗钠药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120801 Assignee: Biochemical Pharmaceutical Factory of Zhuhai S.E.Z. Assignor: Huang Jinxiu Contract record no.: 2013440000331 Denomination of invention: Riboflavin sodium phosphate compound and composition thereof Granted publication date: 20130410 License type: Exclusive License Record date: 20130708 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20151204 Contract record no.: 2013440000331 Assignee after: Zhuhai homologous Pharmaceutical Co., Ltd. Assignee before: Biochemical Pharmaceutical Factory of Zhuhai S.E.Z. |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180104 Address after: 519015 Guangdong city of Zhuhai province Jida West No. 209 Peace Industrial Center Building 2 floor Patentee after: Zhuhai morning Ann Pharmaceutical Co., Ltd. Address before: 519020 Guangdong city of Zhuhai province Jida West No. 209 Peace Industrial Center Building 2 floor Patentee before: Huang Jinxiu |
|
EM01 | Change of recordation of patent licensing contract | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20180329 Contract record no.: 2013440000331 Assignor after: Zhuhai morning Ann Pharmaceutical Co., Ltd. Assignor before: Huang Jinxiu |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: ZHUHAI TONGYUAN PHARMACEUTICAL Co.,Ltd. Assignor: Zhuhai morning Ann Pharmaceutical Co.,Ltd. Contract record no.: 2013440000331 Date of cancellation: 20200610 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120801 Assignee: ZHUHAI TONGYUAN PHARMACEUTICAL Co.,Ltd. Assignor: Zhuhai morning Ann Pharmaceutical Co.,Ltd. Contract record no.: X2020440000096 Denomination of invention: Riboflavin sodium phosphate compound and composition thereof Granted publication date: 20130410 License type: Exclusive License Record date: 20200622 |